TILT Holdings Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Loans Receivable (Tables)

Loans Receivable (Tables)

6 Months Ended

Jun. 30, 2023

A breakdown of the loans receivable terms and balances are as follows:


Loans receivable	June 30, 2023		December 31, 2022
Teneo Fund SPVi LLC Note	$	5,911	$	5,911
Pharma EU, LLC Note		1,410		1,410
A&R Note		710		710
SSZ and Elev8 Note		1,002		1,002
Pure Hana Synergy Note		224		224
Little Beach Harvest Note		5,121		2,199
Total loans receivable	$	14,378	$	11,456
Less allowance for expected credit losses		(13,023)		(7,237)
Loans receivable, net of expected credit losses		1,355		4,219
Less current portion of loan receivable		—		(516)
Loans receivable, long-term	$	1,355	$	3,703

Schedule of Analysis of Credit Quality of Loans Receivable

The following tables present an analysis of the credit quality of loans receivable, together with impairment losses recognized based on lifetime CECL reserves:


	As of June 30, 2023
Nature of collateral	Gross amounts		Loan losses		Net
Security interest in assets of counterparty	$	12,744	$	(11,389)	$	1,355
Third party guarantee		1,410		(1,410)		—
No collateral		224		(224)		—
Net loans receivable	$	14,378	$	(13,023)	$	1,355


	As of December 31, 2022
Nature of collateral	Gross amounts		Loan losses		Net
Security interest in assets of counterparty	$	9,822	$	(5,915)	$	3,907
Third party guarantee		1,410		(1,098)		312
No collateral		224		(224)		—
Net loans receivable	$	11,456	$	(7,237)	$	4,219